On December 14, 2021 Pascal Biosciences Inc. ("Pascal" or the "Company") (TSXV: PAS) (OTC: PSCBF) (FSE: 6PB-FF) reported that it has cancelled its most recent private placement (Press release, Pascal Biosciences, DEC 14, 2021, View Source [SID1234597207]). On October 28, 2021, the Company announced a non-brokered private placement financing of up to $900,000. Pascal has determined in light of market conditions that the current offering should be cancelled until further notice. Pascal is now looking at less dilutive financing options going forward.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!